Skip to main content
|

NIHR Trauma Management MedTech Co-operative holds celebratory launch event

The NIHR Trauma Management MedTech Co-operative (Trauma MIC) officially launched on Wednesday 7 February with an all-day event at the Institute of Translational Medicine (ITM), based on the Queen Elizabeth Hospital Birmingham (QEHB) site.

The Trauma MIC, formerly known as the NIHR Trauma Management Healthcare Technology Co-operative (HTC) from 2012 to 2017, will continue to facilitate innovation in the medical technologies sector for trauma patients.

The launch event featured a variety of speakers and was attended by representatives from industry, the NIHR, local NHS Trusts, charities, and members of the public.

The event highlighted the important role patient and public involvement (PPI) has within research with a lively panel discussion featuring a patient representative. The Trauma MIC is intending to set up a PPI group in the near future, which will directly influence Trauma MIC’s projects and provide useful non-clinical perspectives.

The Trauma MIC’s Clinical Director, Dr Tom Clutton-Brock, from the University of the Birmingham, said: “We’re very pleased that we can build on our successes as a HTC, and can continue to offer usability, regulatory and clinical trials support to industry. We have streamlined our clinical themes, strengthened our PPI team, and are looking forward to another five successful years.”

The Trauma MIC will work closely with the new Medical Devices Testing and Evaluation Centre (MD-TEC), also based in the ITM, which houses state-of-the-art laboratories and purpose-built replicas of clinical areas such as a ward bay and an operating theatre. MD-TEC is funded through the European Regional Development Fund.

The ITM was delivered through Birmingham Health Partners, an alliance between University Hospitals Birmingham NHS Foundation Trust (which operates QEHB), Birmingham Women’s and Children’s NHS Foundation Trust, and the University of Birmingham.


More updates

09/04/2021
Stroke risk for patients with traumatic brain injuries is at its highest in the four months following injury and remains significant for up to five years post-injury, finds a new systematic review led by a team at the University of Birmingham. Traumatic brain injury (TBI) is a global health problem affecting over 60 million people a year worldwide. Incidences of TBI are rising due to a range of…
24/03/2021
A study of top-flight UK rugby players – carried out by the University of Birmingham in collaboration with the Rugby Football Union (RFU), Premiership Rugby, and Marker Diagnostics – has identified a method of accurately diagnosing concussion using saliva, paving the way for the first non-invasive clinical test for concussion for use in sport and other settings. Following the team’s previous re…
23/02/2021
A digital remote care solution including a mobile phone app is helping Covid-19 patients manage their symptoms at home after being developed with the support the West Midlands Academic Health Science Network (WMAHSN). The app developed by medical software company, Dignio, has been implemented by Dudley CCG and allows patients stay at home safely, thus avoiding unnecessary admissions to hospital…
18/02/2021
Their Royal Highnesses The Prince of Wales and The Duchess of Cornwall visited the COVID-19 vaccination centre for University Hospitals Birmingham NHS Foundation Trust (UHB) staff on February 17 2021. Their Royal Highnesses, joined by The Right Honourable Matt Hancock MP, Secretary of State for Health and Social Care, visited the hub here at the Institute of Translational Medicine with key memb…
11/12/2020
An international team of scientists and engineers have been awarded a grant of £768K by UKRI as part of the Newton Fund’s Agile Response Call to develop high performance, low cost ventilators for use in low to middle income countries, it has been announced today. Prompted by a shortage of ventilators in low income countries highlighted by the COVID-19 pandemic, the HPLV project aims to reengin…